Elutia Closes SimpliDerm Sale, Receives $7.7M Cash to Fund NXT-41x Launch
ELUT sits 90% above its 52-week low of $0.5.
Summary
Elutia closed the sale of its SimpliDerm business for $7.7 million in net cash, strengthening its balance sheet to fund NXT-41x through launch. The divestiture is accounted for as a discontinued operation with a $4.9 million gain.
Key Events · M&A and Partnerships · ELUT
-
SimpliDerm Sale Closed
Elutia completed the sale of its SimpliDerm business to Cellution Biologics on August 17, 2026, receiving $7.7 million in net cash at closing (gross $8 million less $0.3 million inventory adjustment).
-
Non-Dilutive Capital for NXT-41x
The $7.7 million in proceeds, combined with previously announced funding, is expected to support operations through the first full year of NXT-41x commercial launch in 2028.
-
Contingent Payments Up to $3M
Elutia may receive up to $2 million for technology transfer milestones and up to $1 million in quarterly earnouts ($250,000 per quarter for five quarters) over the next 18 months.
-
Lien Release on Assets
The company amended its Loan and Security Agreement with Avenue Venture Opportunities Fund II, L.P. to release the lien on the SimpliDerm assets.
Analysis · ELUT · Life Sciences
Elutia completed the sale of its SimpliDerm business to Cellution Biologics, receiving $7.7 million in net cash at closing. The divestiture removes a declining revenue stream but provides non-dilutive capital that extends the company's runway through the NXT-41x commercial launch. The transaction also triggered a lien release on the assets under the Avenue Capital loan, and the pro forma financials show a $4.9 million gain. This is a material step in Elutia's pivot to its drug-eluting biomatrix pipeline, though the company still faces Nasdaq delisting risk and ongoing losses.
At the time of this filing, ELUT was trading at $0.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $42.1M. The 52-week trading range was $0.50 to $2.50. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.